Edition:
India

Adamis Pharmaceuticals Corp (ADMP.OQ)

ADMP.OQ on NASDAQ Stock Exchange Capital Market

3.95USD
15 Jun 2018
Change (% chg)

$-0.20 (-4.82%)
Prev Close
$4.15
Open
$4.10
Day's High
$4.15
Day's Low
$3.83
Volume
70,795
Avg. Vol
93,770
52-wk High
$6.45
52-wk Low
$2.35

Chart for

About

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's... (more)

Overall

Beta: 0.45
Market Cap(Mil.): $165.38
Shares Outstanding(Mil.): 31.35
Dividend: --
Yield (%): --

Financials

  ADMP.OQ Industry Sector
P/E (TTM): -- 30.95 32.75
EPS (TTM): -0.89 -- --
ROI: -68.80 14.84 14.38
ROE: -79.58 16.34 16.07

BRIEF-Adamis Pharmaceuticals Updates Symjepi Commercialization Plans

* ADAMIS PHARMACEUTICALS UPDATES SYMJEPI COMMERCIALIZATION PLANS

23 Feb 2018

BRIEF-Adamis Pharmaceuticals Announces FDA Acceptance For Review For The  Supplemental New Drug Application

* ADAMIS PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE FOR REVIEW FOR THE SUPPLEMENTAL NEW DRUG APPLICATION OF ITS LOW DOSE SYMJEPI PRODUCT CANDIDATE

12 Feb 2018

Competitors

  Price Chg
GlaxoSmithKline plc (GSK.L) 1,556.00 -24.20

Earnings vs. Estimates